Manufacturer : CIP-CIPLA LTD
Composition : PRULIFLOXACIN-600MG
Dose Form : TABLET
Description : PRUFLOX TAB
Route Of Administration : ORAL
Pack : 5
Out of stock
Manufacturer : CIP-CIPLA LTD
Composition : PRULIFLOXACIN-600MG
Dose Form : TABLET
Description : PRUFLOX TAB
Route Of Administration : ORAL
Pack : 5

Drug Ingredient Information



Information for patients
Drug Information Prulifloxacin belongs to category of antibiotics drugs. Prulifloxacin is a type of antibiotics. It is a thiazetoquinoline derivative and is a lipophilic prodrug of ulifloxacin, orally effective antibacterial agent. It has been approved for the treatment of uncomplicated and complicated urinary tract infections, community-acquired respiratory tract infections in Italy and gastroenteritis, including infectious diarrheas,
Drug Alert
Alert no data available
Before Consuming the Medicine
Avoid Drug In the treatment of urinary tract (acute uncomplicated and complicated) and respiratory tract infected AECB.
Drug Special Care Haemolytic reactions may occur in G6PD deficiency patients. Exposure to sun or UV-ray may cause photosensitivity reactions. Lowers seizure threshold and predisposes CNS disorder patients to convulsions. Caution in patients with hypokalaemia, hypocalcaemia, or in patients who suffer from rhythm disorders. Increased risk of Achilles tendon or other tendon damage especially in elderly patients, concurrent corticosteroids-receiving patients or organ transplant recipients. Crystalluria, rhadomyolysis may occur in rare cases. Prolonged use may result in development of drug-resistant bacteria, or superinfections including Clostridium difficile-associated diarrhoea and pseudomembranous colitis. Renal impairment.
Drug Drug Interactions Concurrent use with cimetidine, aluminium- and magnesium-containing antacids, or preparations containing iron and calcium reduces the absorption of Prulifloxacin. Increased concentration with probenecid. Prulifloxacin may increase serum concentration of theophylline. Quinolones may enhance hypoglycaemic effect of hypoglycaemic agents. May enhance effect of oral anticoagulants such as warfarin and its derivatives. Concurrent use of NSAIDS may increase risk of convulsions.
Drug Pregnancy Interaction should not be used in pregnant women or women who may possibly be pregnant. (The safety of prulifloxacin in pregnant women has not been established.) In the teratogenicity study (30, 300 and 3000 mg/kg) in rats, inhibited fetal development was observed at the higher dose, while in the teratogenicity study (10, 30 and 100 mg/kg) in rabbits, increased frequency of premature delivery and fetal death in late pregnancy were noted. However, teratogenic action was not found in these studies.
Drug Breast feeding Interaction It is advisable to avoid using prulifloxacin in lactating mothers. If use of this product is judged to be essential, breastfeeding must be discontinued during treatment.
Drug Machinery Interaction no data available
Drug More Information no data available
How to take the Medicine
Consumption Info no data available
Drug quanitty 600mg as a single dose in the treatment of acute uncomplicated lower UTIs, and as a once daily 600mg dosage for a maximum of 10 days in the treatment of complicated lower UTIs.
Drug Dose no data available
Excess Drug Consumption Dail 1066. OR Contact doctor immediately
Forgot Drug Consumption Contact Your doctor
Stop Drug Consumption Do not stop the drug untill your doctor says you to do so.
Possible Side Effects
General Information no data available
Common Drug Side Effects Blood dyscrasias CNS disorders Gastrointestinal disorders Urticaria (occasional)
Rare Drug Side Effects no data available
Very Rare Drug Side Effects no data available
Drug Side Effects Symptoms no data available
How to Store the Medicine
How to Store the Medicine Store below 25°C

Substitute Drugs

Write Your Own Review
You're reviewing:PRUFLOX TABLET
Your Rating